Houyuan Chen, Hailong Hu, Chong Shen, Yunkai Qie, Zhouliang Wu, Yiduo Bai, Zhe Zhang, Shiwang Huang, Kaipeng Jia, Peng Li, Yuda Lin, Zihan Xue. "Neoadjuvant tislelizumab combined with disitamab vedotin (RC48) for patients with Her-2 expressing upper tract urothelial carcinoma: A pilot study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16588